Raymond James & Associates’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $1.82M | Sell |
|
|||||
|
2024
Q1 | $3.47M | Buy |
|
|||||
|
2023
Q4 | $1.72M | Sell |
|
|||||
|
2023
Q3 | $1.33M | Buy |
|
|||||
|
2023
Q2 | $1.97M | Buy |
|
|||||
|
2023
Q1 | $2M | Buy |
|
|||||
|
2022
Q4 | $2.71M | Buy |
|
|||||
|
2022
Q3 | $5.99M | Buy |
|
|||||
|
2022
Q2 | $2.16M | Buy |
|
|||||
|
2022
Q1 | $3.02M | Buy |
|
|||||
|
2021
Q4 | $2.36M | Buy |
|
|||||
|
2021
Q3 | $1.81M | Buy |
|
|||||
|
2021
Q2 | $2.91M | Buy |
|
|||||
|
2021
Q1 | $2.89M | Sell |
|
|||||
|
2020
Q4 | $2.61M | Sell |
|
|||||
|
2020
Q3 | $1.9M | Buy |
|
|||||
|
2020
Q2 | $3.71M | Buy |
|
|||||
|
2020
Q1 | $124K | Buy |
|
|||||
|
2019
Q4 | $233K | Buy |
|